Proparacaine Hydrochloride Ophthalmic Solution USP, 0.5% (Sterile)

Manufacturer
H.J. Harkins Company, Inc. | Bausch & Lomb Incorporated
Effective date
2012-04-19
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 20:14:55

Label at a glance#

ProductProparacaine Hydrochloride
Active ingredientPROPARACAINE HYDROCHLORIDE
Label structure12 sections

Indications and uses

Proparacaine hydrochloride ophthalmic solution is indicated for topical anesthesia in ophthalmic practice. Representative ophthalmic procedures in which the preparation provides good local anesthesia include measurement of intraocular pressure (tonometry), removal of foreign bodies and sutures from the cornea, conjunctival scraping in diagnosis and gonioscopic examination; it is also indicated for use as a topical...

Dosage and administration

Deep anesthesia as in cataract extraction: Instill 1 drop every 5 to 10 minutes for 5 to 7 doses. Removal of sutures: Instill 1 or 2 drops 2 or 3 minutes before removal of stitches. Removal of foreign bodies: Instill 1 or 2 drops prior to operating. Tonometry: Instill 1 or 2 drops immediately before measurement FOR OPHTHALMIC USE ONLY

Storage and handling

Refrigerate at 2°-8°C (36°- 46°F). Protect from light. Keep tightly closed. Do not use if the solution shows more than a faint yellow color. DO NOT USE IF IMPRINTED NECKBAND IS NOT INTACT. KEEP OUT OF REACH OF CHILDREN. Rx only Bausch & Lomb Incorporated Tampa, FL 33637 ©Bausch & Lomb Incorporated Revised November 2007 9114400 (Folded) 9114500 (Flat)

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Rx only

DESCRIPTION:

DESCRIPTION SECTION

Proparacaine Hydrochloride Ophthalmic Solution USP, 0.5% is a topical anesthetic prepared as a sterile aqueous ophthalmic solution. The active ingredient is represented by the following structural formula:

Proparacaine Hydrochloride (structural formula)
Proparacaine Hydrochloride (structural formula)

C16H26N2O3 • HCI

Mol. wt.: 330.85

Chemical name: Benzoic acid, 3-amino-4-propoxy-,2-(diethylamino) ethyl ester, monohydrochloride.

Each mL Contains:

ACTIVE: Proparacaine Hydrochloride 5 mg (0.5%); INACTIVES: Glycerin, Hydrochloric Acid, Purified Water. Hydrochloric Acid and/or Sodium Hydroxide may be added to adjust pH (3.5 – 6.0). PRESERVATIVE ADDED: Benzalkonium Chloride 0.01%.

CLINICAL PHARMACOLOGY:

CLINICAL PHARMACOLOGY SECTION

Proparacaine is a rapid acting local anesthetic suitable for ophthalmic use. With a single drop, the onset of anesthesia usually begins within 30 seconds and persists for 15 minutes or longer.

The main site of anesthetic action is the nerve cell membrane where proparacaine interferes with the large transient increase in the membrane permeability to sodium ions that is normally produced by a slight depolarization of the membrane. As the anesthetic action progressively develops in a nerve, the threshold for electrical stimulation gradually increases and the safety factor for conduction decreases. When this action is sufficiently well developed, block of conduction is produced.

The exact mechanism whereby proparacaine and other local anesthetics influence the permeability of the cell membrane is unknown; however, several studies indicate that local anesthetics may limit sodium ion permeability by closing the pores through which the ions migrate in the lipid layer of the nerve cell membrane. This limitation prevents the fundamental change necessary for the generation of the action potential.

INDICATIONS AND USAGE:

INDICATIONS & USAGE SECTION

Proparacaine hydrochloride ophthalmic solution is indicated for topical anesthesia in ophthalmic practice. Representative ophthalmic procedures in which the preparation provides good local anesthesia include measurement of intraocular pressure (tonometry), removal of foreign bodies and sutures from the cornea, conjunctival scraping in diagnosis and gonioscopic examination; it is also indicated for use as a topical anesthetic prior to surgical operations such as cataract extraction.

CONTRAINDICATIONS:

CONTRAINDICATIONS SECTION

This preparation is contraindicated in patients with known hypersensitivity to any component of the solution.

WARNINGS:

WARNINGS SECTION

NOT FOR INJECTION - FOR TOPICAL OPHTHALMIC USE ONLY

Prolonged use of a topical ocular anesthetic may produce permanent corneal opacifiction with accompanying loss of vision.

PRECAUTIONS:

PRECAUTIONS SECTION

General:

GENERAL PRECAUTIONS SECTION

Proparacaine should be used cautiously and sparingly in patients with known allergies, cardiac disease, or hyperthyroidism. The long-term toxicity of proparacaine is unknown; prolonged use may possibly delay wound healing. Although exceedingly rare with ophthalmic application of local anesthetics, it should be borne in mind that systemic toxicity (manifested by central nervous system stimulation followed by depression) may occur.

Protection of the eye from irritating chemicals, foreign bodies and rubbing during the period of anesthesia is very important. Tonometers soaked in sterilizing or detergent solutions should be thoroughly rinsed with sterile distilled water prior to use. Patients should be advised to avoid touching the eye until the anesthesia has worn off. Do not touch dropper tip to any surface as this may contaminate the solution.

Carcinogenesis, Mutagenesis, Impairment of Fertility:

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

Long-term studies in animals have not been performed to evaluate carcinogenic potential, mutagenicity, or possible impairment of fertility in males or females.

Pregnancy:

PREGNANCY SECTION

Teratogenic Effects: Pregnancy Category C: Animal reproduction studies have not been conducted with proparacaine hydrochloride ophthalmic solution. It is also not known whether proparacaine hydrochloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Proparacaine hydrochloride should be administered to a pregnant woman only if clearly needed.

Nursing Mothers:

NURSING MOTHERS SECTION

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when proparacaine hydrochloride is administered to a nursing woman.

Pediatric Use:

PEDIATRIC USE SECTION

Controlled clinical studies have not been performed with proparacaine hydrochloride ophthalmic solution to establish safety and effectiveness in pediatric patients; however, the literature cites the use of proparacaine hydrochloride as a topical ophthalmic anesthetic agent in pediatric patients.

ADVERSE REACTIONS:

ADVERSE REACTIONS SECTION

Pupillary dilation or cycloplegic effects have rarely been observed with proparacaine hydrochloride. The drug appears to be safe for use in patients sensitive to other local anesthetics, but local or systemic sensitivity occasionally occurs. Instillation of proparacaine in the eye at recommended concentration and dosage usually produces little or no initial irritation, stinging, burning, conjunctival redness, lacrimation or increased winking. However, some local irritation and stinging may occur several hours after the instillation.

Rarely, a severe, immediate-type, apparently hyperallergic corneal reaction may occur which includes acute, intense and diffuse epithelial keratitis; a gray, ground-glass appearance; sloughing of large areas of necrotic epithelium; corneal filaments and, sometimes, iritis with descemetitis.

Allergic contact dermatitis with drying and fissuring of the fingertips has been reported.

Softening and erosion of the corneal epithelium and conjunctival congestion and hemorrhage have been reported.

DOSAGE AND ADMINISTRATION:

DOSAGE & ADMINISTRATION SECTION

Deep anesthesia as in cataract extraction:

Instill 1 drop every 5 to 10 minutes for 5 to 7 doses.

Removal of sutures:

Instill 1 or 2 drops 2 or 3 minutes before removal of stitches.

Removal of foreign bodies:

Instill 1 or 2 drops prior to operating.

Tonometry:

Instill 1 or 2 drops immediately before measurement

FOR OPHTHALMIC USE ONLY

HOW SUPPLIED:

HOW SUPPLIED SECTION

Proparacaine Hydrochloride Ophthalmic Solution USP, 0.5% is supplied in a plastic bottle with a controlled drop tip in the following size:

15 mL bottle - Prod. No. 04711

Storage

STORAGE AND HANDLING SECTION

Refrigerate at 2°-8°C (36°- 46°F). Protect from light. Keep tightly closed.

Do not use if the solution shows more than a faint yellow color.

DO NOT USE IF IMPRINTED NECKBAND IS NOT INTACT.

KEEP OUT OF REACH OF CHILDREN.

Rx only

Bausch & Lomb Incorporated
Tampa, FL 33637
©Bausch & Lomb Incorporated

Revised November 2007

9114400 (Folded)
9114500 (Flat)

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Proparacaine Hydrochloride Ophthalmic Solution USP, 0.5% (Carton, 15 mL - Bausch & Lomb)
Proparacaine Hydrochloride Ophthalmic Solution USP, 0.5% (Carton, 15 mL - Bausch & Lomb)

NDC 24208-730-06

Bausch & Lomb

Proparacaine Hydrochloride Ophthalmic Solution USP, 0.5% (Sterile)

Rx only

[icon- eye] [icon- 0.5%] [icon-solution] [icon- 15 mL]

Repacked by:

H.J. Harkins Company, Inc.

Nipomo, CA 93444

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1191013proparacaine HCl 0.5 % Ophthalmic SolutionPSN2
1191013proparacaine hydrochloride 5 MG/ML Ophthalmic SolutionSCD2
1191013proparacaine hydrochloride 0.5 % Ophthalmic SolutionSY2

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
PROPARACAINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
9ba0893a-4390-4124-b66b-ffd4f2b29a0eProduct name220260305

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
52959-705-012019-11-13C16284748780-197449f38-b8d9-f6ea-e053-dbdaa90aa703Proparacaine Hydrochloride Ophthalmic Solution USP, 0.5% (Sterile)

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
52959-705-01Proparacaine Hydrochloride1 in 1 CARTONSOLUTION/ DROPS12
52959-705-01Proparacaine Hydrochloride15 mL in 1 BOTTLE, DROPPERSOLUTION/ DROPS152

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
52959-705PROPARACAINE HYDROCHLORIDE SOLUTION/ DROPS [H.J. HARKINS COMPANY, INC.]2Legacy NDC, 2 package rows20120423_522987a1-d52e-4819-9ce4-53fd17c126c2.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
24208-730-06ML - Milliliter24208-7304aacb9e2-351b-4cc5-bfee-c49a6d2147d612012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
PROPARACAINE HYDROCHLORIDEACTIVE INGREDIENTU96OL57GOY2
PROPARACAINEACTIVE MOIETYB4OB0JHI1X2
BENZALKONIUM CHLORIDEINACTIVE INGREDIENTF5UM2KM3W72
GLYCERININACTIVE INGREDIENTPDC6A3C0OX2
HYDROCHLORIC ACIDINACTIVE INGREDIENTQTT17582CB2
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32I2
WATERINACTIVE INGREDIENT059QF0KO0R2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
52959-70552959-705-01
24208-730

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 4 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION/ DROPS / OPHTHALMICADJ PHExact identifier — unii+route+dosage form
GLYCERINGLYCERINPDC6A3C0OXSOLUTION/ DROPS / OPHTHALMIC12 mgExact identifier — unii+route+dosage form
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7SOLUTION/ DROPS / OPHTHALMIC1 mgExact identifier — unii+route+dosage form
HYDROCHLORIC ACIDHYDROCHLORIC ACIDQTT17582CBSOLUTION/ DROPS / OPHTHALMICADJ PHExact identifier — unii+route+dosage form

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A040074-001PROPARACAINE HYDROCHLORIDEPROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-29

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A040074-001AT

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-2984e616aacf4f…
2026-08-18 06:07:402026-07A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-29caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-29011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-2931067a03dcf5…
2025-08-23 18:47 UTC2025-08A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-296a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-29fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-29b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-2903ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-292680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-295bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-29d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-29d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-2979d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-29301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-291e350fbaab3a…
2024-05-31 18:47 UTC2024-05A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-298072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-295c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-295d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-294b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-2974a2ff9319b5…
2022-03-09 01:35 UTC2022-03A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-29bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-29782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-2987673890dc5c…
2021-03-12 10:30 UTC2021-03A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-295aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-298869cabd3fbd…
2020-11-12 02:37 UTC2020-11A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-29c0c555d07b60…
2019-12-14 00:12 UTC2019-12A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-293f01610625f2…
2019-09-15 20:21 UTC2019-09A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-29b00525d2431f…
2019-07-19 19:46 UTC2019-07A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-29ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-296a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-291c564ffb4f44…
2023-12-20 04:57 UTC2023-12A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-29ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-29a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATRS1995-09-299b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-29a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-293f0d92c62455…
2023-05-13 08:27 UTC2023-05A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-29053a50430f4f…
2023-01-26 05:58 UTC2023-01A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-293bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-293a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A040074-001PROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICAT1995-09-29f41ea6bd6efb…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A040074-001AT184e616aacf4f…
2026-08-18 06:07:402026-07A040074-001AT1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A040074-001AT1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A040074-001AT131067a03dcf5…
2025-08-23 18:47 UTC2025-08A040074-001AT16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A040074-001AT1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A040074-001AT1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A040074-001AT103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A040074-001AT12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A040074-001AT15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A040074-001AT1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A040074-001AT1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A040074-001AT179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A040074-001AT1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A040074-001AT11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A040074-001AT18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A040074-001AT15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A040074-001AT15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A040074-001AT14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A040074-001AT174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A040074-001AT1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A040074-001AT1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A040074-001AT187673890dc5c…
2021-03-12 10:30 UTC2021-03A040074-001AT15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A040074-001AT18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A040074-001AT1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A040074-001AT13f01610625f2…
2019-09-15 20:21 UTC2019-09A040074-001AT1b00525d2431f…
2019-07-19 19:46 UTC2019-07A040074-001AT1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A040074-001AT16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A040074-001AT11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A040074-001AT1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A040074-001AT1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A040074-001AT19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A040074-001AT1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A040074-001AT13f0d92c62455…
2023-05-13 08:27 UTC2023-05A040074-001AT1053a50430f4f…
2023-01-26 05:58 UTC2023-01A040074-001AT13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A040074-001AT13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A040074-001AT1f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Proparacaine HydrochloridePROPARACAINE HYDROCHLORIDEBausch & Lomb Incorporatedb699f838-8b69-4bac-953b-ea8822ec19fc2023-09-01Warnings, Adverse reactionsExact identifier
ndc (product): 24208-730
a979a931-8857-48a2-b369-d17c814d7ece522987a1-d52e-4819-9ce4-53fd17c126c22012-04-19Warnings, Adverse reactionsExact identifier
spl id: a979a931-8857-48a2-b369-d17c814d7ece
spl set id: 522987a1-d52e-4819-9ce4-53fd17c126c2

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.